Injecting botulinum toxin at different depths is not effective for the correction of eyebrow asymmetry

Dermatologic Surgery

Volumn 41, Issue , 2015, Pages S82-S87

  Sneath, Jason ^a   Humphrey, Shannon ^a   Carruthers, Alastair ^a   Carruthers, Jean ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP INJECTION DEPTH; EYEBROW; EYEBROW ASYMMETRY; FACE ASYMMETRY; FEMALE; FOLLOW UP; HUMAN; INJECTION; INJECTION SITE; INTERMETHOD COMPARISON; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHALLOW INJECTION DEPTH; SKIN DEFECT; TREATMENT OUTCOME; CLINICAL TRIAL; DRUG THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES;

ADULT; BOTULINUM TOXINS, TYPE A; EYEBROWS; FACIAL ASYMMETRY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES;

EID: 84920742687     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1097/DSS.0000000000000159     Document Type: Article

References (11)

1. Kowner R. Facial asymmetry and attractiveness judgment in developmental perspective. J Exp Psychol Hum Percept Perform 1996; 22:662-75.
2. Springer IN, Wannicke B, Warnke PH, Zernial O, et al. Facial attractiveness: visual impact of symmetry increases significantly towards the midline. Ann Plast Surg 2007;59:156-62.
3. Muhlbauer W, Holm C. Eyebrow asymmetry: ways of correction. Aesthetic Plast Surg 1998;22:366-71.
4. Koch RJ, Troell RJ, Goode RL. Contemporary management of the aging brow and forehead. Laryngoscope 1997;107:710-5.
5. Carruthers A, Carruthers J. A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy. J Am Acad Dermatol 2009;60:972-9.
6. Carruthers A, Carruthers J, Cohen J. A prospective, doubleblind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides. Dermatol Surg 2003;29:461-7.
7. Carruthers JA, Lowe NJ, Menter MA, Gibson J, et al; Botox Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinumtoxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-9.
8. Trindade de Almeida AR, Marques E, de Almeida J, Cunha T, et al. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg 2007;33: S37-43.
9. Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg 2000;105:1129-35.
10. Huang W, Rogachefsky AS, Foster JA. Brow lift with botulinum toxin. Dermatol Surg 2000;26:55-60.
11. Carruthers A, Carruthers J. Eyebrow height after botulinum toxin type A to the glabella. Dermatol Surg 2007;33:S26-31.